Log in
Enquire now
Be Biopharma

Be Biopharma

Be Biopharma is developing a proprietary class of engineered B cells as medicines in applications beyond cytotoxicity.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
B2X
B2B
B2B
CEO
‌
Joanne Smith-Farrell
0
CFO
‌
Angus Smith
Competitors
Aphios
Aphios
0
Arqule
Arqule
0
‌
Matterworks
0
Country
United States
United States
0
Crunchbase URL
crunchbase.com/organiz...iopharma
Email Address
info@bebiopharma.com
Founded Date
2020
Industry
Biotechnology
Biotechnology
Health technology
Health technology
Technology
Technology
Investors
Bristol-Myers Squibb
Bristol-Myers Squibb
Alta Partners
Alta Partners
Atlas Venture
Atlas Venture
Longwood Fund
Longwood Fund
Takeda Ventures
Takeda Ventures
RA Capital Management
RA Capital Management
ARCH Venture Partners
ARCH Venture Partners
Latest Funding Round Date
October 22, 2024
Latest Funding Round Amount (USD)
82,000,000
Latest Funding Type
Series B
Series B
LinkedIn URL
@company/be-biopharma-inc
Location
Cambridge, Massachusetts
Cambridge, Massachusetts
0
Number of Employees
65
Number of Employees (Ranges)
51 – 200
Total Funding Amount (USD)
264,000,000
Twitter URL
@bebiopharma
Official Website
be.bio

Find more companies like Be Biopharma

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.